Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Rigel Pharmaceutical Inc. buy klostergang

Start price
€2.93
18.04.17 / 50%
Target price
€3.61
10.05.17
Performance (%)
-20.62%
End price
€2.33
10.05.17
Summary
This prediction ended on 10.05.17 with a price of €2.33. The prediction for Rigel Pharmaceutical Inc. disappointed with a performance of -20.62%. klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Rigel Pharmaceutical Inc. -4.927% -4.927% -28.473% -71.223%
iShares Core DAX® 1.851% 5.158% 17.711% 19.954%
iShares Nasdaq 100 1.573% 2.589% 39.053% 56.636%
iShares Nikkei 225® -0.412% -2.857% 13.501% 7.721%
iShares S&P 500 1.128% 2.485% 29.871% 47.507%

Comments by klostergang for this prediction

In the thread Rigel Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -20.62%
Target price 3.608
Change
Ends at 10.05.17

klostergang stimmt der Buy-Einschätzung von tamam zu

klostergang stimmt am 18.04.2017 der Buy-Einschätzung von tamam mit dem Kursziel 4$ zu.
Überschrift: Rigel Pharmaceuticals (NASDAQ:RIGL) submits a New Drug Application

Prediction Buy
Perf. (%) -20.62%
Target price 3.608
Change
Ends at 10.05.17

(Vom Mitglied beendet)

Stopped prediction by klostergang for Rigel Pharmaceutical Inc.

Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€3.32
14.07.20
€1.00
04.11.21
4.88%
17.06.21

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.79
23.01.19
€5.05
14.07.20
84.97%
14.07.20